Non-ST Elevation Myocardial Infarction (NSTEMI) – A Case Study
Polycythemia vera (PV) is a chronic myeloproliferative disorder characterized by a high risk of developing arterial and venous thromboembolic complications. In recent years, great insight has been gained into the understanding of the pathogenesis of thrombosis in PV. Diagnosing and managing a case of acute coronary syndrome (ACS) due to non-atherosclerotic causes is a challenge. In this case report, we share our experience in diagnosis, management and revascularization issues in non-ST-elevation myocardial infarction (NSTEMI) in a patient with polycythemia vera background.
2. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999-3054.
3. de Winter RJ, Tijssen JGP. Non–ST–segment elevation myocardial infarction revascularization for everyone? JACC: Cardiovascular Interventions. 2012;5(9):903-905. DOI: 10.1016/j.jcin.2012.07.001
4. Van Horn SE Jr, Manju CV. Management of non–ST–segment elevation myocardial infarction. Medical Clinics of North America. 2007;91(4):683-700.
5. Benjamin D, Yeshurun D, Charnilas J, Pinkhas J. Hyperlipidemia and myocardial infarction among 118 patients with polycythemia vera. Am J Med Sci. 1978;276:23-26.
6. Cheitlin MD, McAllister HA, de Castro CM. Myocardial infarction without atherosclerosis. The Journal of the American Medical Association. 1975;231:951-959.
7. Bob-Manuel T, Ifedili I, Reed G, Ibebougu UN, Khozam RN. Non-ST elevation acute coronary syndromes: A comprehensive review. Current Problems in Cardiology. 2017;42(9): 266-305.
8. Dolai TK, Mandal PK. Non-ST-segment elevation myocardial infarction (NSTEMI) in a 43-year-old man – Uncommon etiology. Journal of Indian College of Cardiology. 2014;4:277-280.
9. Bahbahani H, Aljenaee K, Bella A. Polycythemia vera presenting as acute myocardial infarction: An unusual presentation. J Saudi Heart Assoc. 2015;27:57-60.
10. Hosoya H, Levine JJ, Henry DH, Goldberg S. Double the trouble: Acute coronary syndrome and ischemic stroke in polycythemia vera. The American Journal of Medicine. 2017;130(6):e237-e240.
11. Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood. 1984;64: 1-12.
12. Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin Hematol. 1986;23:177-182.
13. Venegoni P, Schroth G. Myocardial infarction and polycythemia vera: How should we treat it? Cathet Cardiovasc Diagn. 1994;32:259-261.
14. Adel G, Aoulia D, Amina Y, Aymen BA, Abdel-Hamid NM Polycythemia vera and acute coronary syndromes: Pathogenesis, risk factors and treatment. Journal of Hematology and Thromboembolic Diseases. 2013;1:107. DOI: 10.4172/2329-8790.1000107